6 completed, 1 unknown, 1 withdrawn. 8 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 6, Unknown 1, Withdrawn 1 |
| Phase 2 | 3 | Completed 2, Withdrawn 1 |
Follow Homosexuality: new trials by email Literature Review of Homosexuality trials Research Report on Homosexuality
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mobile Phone App for Depression and Anxiety in Young Men Who Are Attracted to Men Mobile Phone Application - Depressive Symptoms, Anxiety Generalized | Phase 1 / Phase 2 | Withdrawn | Northwestern University | 2017-08-14 | 2017-08-17 | |
| Oxytocin HIV Meth Study Oxytocin, Placebo - Amphetamine Use Disorders | Phase 1 | Completed | University of California, San Francisco | 48 | 2017-01-01 | 2019-03-05 |
| Alcohol and Implicit Process in Sexual Risk Behavior in MSM Alcohol, Placebo (non-alcoholic beverage) - Alcohol Drinking, Sex Behavior | Phase 1 | Completed | Syracuse University | 260 | 2016-05-01 | 2021-07-23 |
| Behavioral Activation and HIV Risk Reduction for Men Who Have Sex With Men With Crystal Meth Abuse Behavioral Activation Therapy and Risk Reduction Counseling (BAT-RR), Information, Motivation, Behavioral skills change approach to sexual risk reduction - Crystal Methamphetamine Abuse, Crystal Methamphetamine Dependence | Phase 1 | Unknown | Massachusetts General Hospital | 50 | 2011-01-01 | 2012-06-01 |
| Stonewall Treatment Evaluation Project Stonewall Project - Substance Abuse, HIV Infections | Phase 1 / Phase 2 | Completed | University of California, San Francisco | 150 | 2010-03-01 | 2014-10-27 |
| Evaluation of Many Men, Many Voices, An STD/HIV Prevention Intervention for Black MSM Many Men, Many Voices (3MV) - HIV Infections, Sexually Transmitted Diseases | Phase 1 / Phase 2 | Completed | Centers for Disease Control and Prevention | 341 | 2005-08-01 | 2010-06-24 |
| Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With Men (MSM) Bupropion, Placebo - HIV Infections, Depression | Phase 1 | Completed | NYU Langone Health | 41 | 2002-09-01 | 2017-12-12 |
| A Study of the Effects of Advantage 24 on the Rectum Nonoxynol-9 - HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 70 | 2021-10-29 |
HIV Infections (4) · Depression (2) · Homosexuality, Male (2) · Multiple Endocrine Neoplasia Type 1 (2) · Sexual Behavior (2) · Substance-Related Disorders (2) · Acquired Immunodeficiency Syndrome (1) · Alcohol Drinking (1) · Alzheimer Disease (1) · Anxiety Disorders (1) · Behavior, Addictive (1) · Bisexuality (1) · Generalized Anxiety Disorder (1) · Patient Compliance (1)
Behavior (8) · Sexuality (8) · Sexual Behavior (6) · Blood-Borne Infections (4) · Communicable Diseases (4) · Genital Diseases (4) · Immune System Diseases (4) · Immunologic Deficiency Syndromes (4) · Infections (4) · Lentivirus Infections (4) · RNA Virus Infections (4) · Retroviridae Infections (4) · Sexually Transmitted Diseases, Viral (4) · Urogenital Diseases (4) · Virus Diseases (4)
Bupropion (1) · Ethanol (1) · Nonoxynol (1) · Oxytocin (1) · Sodium Chloride (1)
University of California, San Francisco (2) · Centers for Disease Control and Prevention (1) · Massachusetts General Hospital (1) · NYU Langone Health (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Northwestern University (1) · Syracuse University (1)
United States (8)
Adam W Carrico, Ph.D. (1) · Chris Stauffer, MD (1) · Connie Celum (1) · Jeffrey H Herbst, PhD (1) · Jeffrey Simons, PhD (1) · Matthew Mimiaga, ScD (1) · Michael D. Siever, Ph.D. (1) · Michael Marmor, PhD (1) · Michelle N Burns, Ph.D. (1) · Steve A Maisto, PhD (1) · Susan Buchbinder (1) · Thomas M Painter, PhD (1) · Tibor P.A. Palfai, PhD (1) · William J Woods, Ph.D. (1)
PMID 19267264, PMID 24743663, PMID 30791944, PMID 34697392
K08MH094441 (1), R01AA022301 (1), R01DA015303 (1)